#436: Do ISO 13485's Production Controls apply to SaMD?

Global Medical Device Podcast · 8 Dec 2025 · 43m · Episode 436

What this episode covers

Adnan Ashfaq, founder of Simply Medica, explains how to apply ISO 13485 production controls to Software as a Medical Device (SaMD), arguing that hardware-centric clauses must be interpreted in a 'virtual manufacturing space.' He details the validation of Software of Unknown Provenance (SOUP) as purchased components, the necessity of a Software Bill of Materials (SBoM), and the integration of FDA Computer Software Assurance (CSA) guidance. The discussion covers specific ISO clauses including 7.5 (Production), 7.4 (Purchasing), 6.3/6.4 (Resources/Environment), and 7.3.8 (Design Transfer), emphasizing that agile development requires rigorous documentation to satisfy regulatory audits.

Mentioned

Companies
Simply Medica, AWS, Microsoft, FDA, Greenlight Guru, NHS
Tools
GitHub, GitLab
Also
ISO 13485, IEC 62304, GAMP, HIPAA, GDPR

Other shows on the same ground, closest first.

  • Let's Combinate · 41m

    134 - ISO62304, Software Development Process, SaMD, Closed Loop Systems, Complexities with Cloud and Better Software in MedTech with Richard Koch

    Richard Koch, founder of KochSaMD, explains the complexities of developing cloud-based medical devices, using a closed-loop insulin pump system as a primary case study. He details how ISO 62304 governs software development within the broader ISO 13485 framework, emphasizing the shift from batch-based physical manufacturing to continuous, high-velocity software updates. Koch warns that tech giants like Apple and Google are disrupting the industry by leveraging their digital expertise to acquire or compete with traditional medtech firms, urging leaders to upskill in software development to survive.

  • Let's Combinate · 1h 03m

    021 - "Options" with Karandeep Singh Badwal

    Karandeep Singh Badwal, a QA/RA consultant and host of The MedTech Podcast, explains how defining 'intended use' determines whether a product is a regulated medical device or unregulated software, a critical distinction for startups. He details the specific regulatory challenges of Software as a Medical Device (SaMD), including cybersecurity, GDPR compliance, and the impact of the EU MDR on software classification. Badwal also discusses the strategic advantages for UK software companies post-Brexit, where they can still self-certify as Class 1 devices while EU counterparts face stricter notified body audits.

  • Let's Combinate · 9m

    170 - The #1 Secret to Understanding ISO 13485 (You’ll Wish You Knew Sooner)

    Subhi Saadeh, host of Let's Combinate and Quality Professional, explains how viewing ISO 13485 through the lens of interconnected Plan-Do-Check-Act (PDCA) cycles simplifies implementation for medical device and combination product companies. He contrasts the standard's framework approach with mandatory regulations like 21 CFR 820, demonstrating how each clause from QMS (Clause 4) to Design and Development maps to specific PDCA stages. Saadeh argues that this perspective shifts ISO 13485 from a static rule book to a dynamic guide for continuous improvement and real-world process effectiveness.

  • Let's Combinate · 44m

    090 - Software Validation, Automation, No-Code Quality Tools and QMS with Harsh Thakkar

    Harsh Thakkar, CEO of Qualtivate, explains how life sciences companies can automate quality management systems (QMS) using no-code tools like Zapier and Make to reduce manual reporting burdens. He details the regulatory framework for software validation, distinguishing between out-of-the-box, configured, and custom software categories defined in GAMP 5. Thakkar emphasizes that validation should focus on intended use and risk rather than validating the entire system, citing the FDA's Computer Software Assurance (CSA) guidance as a way to reduce documentation burdens.

  • Let's Combinate · 10m

    198 - QMSR Explained, ISO 13485 Compared, and 5 Key Things You Might’ve Missed

    Subhi Saadeh, host of Let's Combinate and Quality Professional, breaks down five critical aspects of the FDA's new Quality Management System Regulation (QMSR). He explains that while QMSR harmonizes with ISO 13485, it retains 21 CFR 820 with FDA-specific overlays like UDI and complaint handling, and removes previous exemptions for certain manufacturers. Saadeh emphasizes that risk management remains mandatory despite not being explicitly named in the text, and warns that companies must complete gap assessments and training before the February 2, 2026 compliance deadline.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.